Chronic Hemodialysis Catheter Market Size, Share & Trends Analysis Report By Type of Tip (Step-Tip Catheters, Split-Tip Catheters, Symmetric Tip Catheters), By Material (Silicone, Polyurethane), By End User (In-Center Dialysis, Home Dialysis) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The global chronic hemodialysis catheter market size was valued at USD 392.17 million in 2022. It is projected to reach USD 537.74 million by 2031, growing at a CAGR of 3.57% during the forecast period (2023-2031). Factors such as increasing adoption of hemodialysis catheters and rising cases of end stage renal disease, significantly drives the chronic hemodialysis catheter market demand by 2031.

Hemodialysis is a method of blood filtration for individuals with kidney failure. Dialysis is performed by connecting a patient to a dialysis machine via a catheter. Catheter lumens (flexible tubular passage) for blood exchange are colored red and blue for easy identification during the dialysis process. The red-colored lumen (atrial lumen) draws blood from a patient and transfers it to the dialysis machine for filtration, whereas the blue-colored lumen (venous lumen) returns blood to the patient after dialysis machine filtration. A catheter is inserted into one of the large veins, such as the superior vena cava, or by puncturing the internal jugular vein in the neck in order to advance it into the chest. Blood flow through a catheter ranges from 200 to 500 milliliters per minute. Available hemodialysis catheter products include cuffed tunneled catheters, non-cuffed tunneled catheters, and non-tunneled catheters.

Market Dynamics

What are the primary factors driving the chronic hemodialysis catheter market?

Increasing adoption of hemodialysis catheters

Patients are compelled to use dialysis products and services due to the rise in the incidence of kidney diseases, which drives the demand for hemodialysis catheters. Hemodialysis catheters provide temporary vascular access to correct metabolic imbalances resulting from renal dysfunction. Doctors recommend permanent vascular access for dialysis, which has lower rates of complications and greater efficiency; however, the demand for catheters continues to rise due to various patient health-related factors. Patients' advancing age and comorbid conditions, such as diabetes and vascular disease, can impede the formation and maintenance of fistulas and grafts. Some of the reasons for the continued use of hemodialysis catheters are the delayed referral to a nephrologist for the creation of an arteriovenous fistula (AFV) and the failure of fistulas or grafts. Consequently, the rise in hemodialysis catheter usage is anticipated to propel the chronic hemodialysis catheter market during the forecast period.

Rising cases of end stage renal disease

Globally, chronic kidney disease (CKD) is becoming more prevalent. According to the Centers for Disease Control and Prevention, approximately 15% of U.S. adults have chronic kidney disease (CKD). According to the United States Renal Data System (USRDS), 124,500 new cases of ESRD were reported in the United States in 2017. If not properly treated, CKD can progress to end-stage renal disease (ESRD). In the United States, nearly 786,000 people are living with end-stage renal disease (ESRD). The National Institute of Diabetes and Digestive and Kidney Diseases reports that 71% of these patients are on dialysis, and 29% receive a kidney transplant. ESRD is the most advanced stage of kidney disease, in which dialysis or kidney transplantation is required to sustain life. Thus, it is anticipated that the increase in ESRD patients will generate demand for dialysis and hemodialysis catheter products.

What are the main factors that will slow down the chronic hemodialysis catheter market?

Complications linked hemodialysis catheters

Following angioplasty, restenosis refers to a decrease in the diameter of the vessel lumen. A minimally invasive revascularization technique called percutaneous transluminal angioplasty (PTA) is used to treat atherosclerotic lesions in the peripheral area. Due to recurrent stenosis (restenosis), a significant drawback of percutaneous angioplasty that restricts the widespread use of this minimally invasive technique, late clinical failure occurs in 60% of patients (within the first 12 months) following primarily successful interventions. Decreased endothelial function, elevated platelet activity, and a more aggressive cellular response to injury are additional characteristics of diabetic patients. Additionally, patients with diabetes are more likely to experience restenosis, which limits market expansion.

What are the future opportunities for the chronic hemodialysis catheter market?

Increasing adoption of home hemodialysis

Home hemodialysis is a method of hemodialysis that can be performed at home. Home hemodialysis offers numerous advantages, including the option to perform treatment more frequently and for longer durations without interruption. There are two types of home hemodialysis treatments: short and daily hemodialysis and traditional home hemodialysis, which can be performed up to three times per week for four-hour sessions. The option of home hemodialysis enables patients to gain control over dialysis and enhances their quality of life. In order to better manage the dialysis process, the cumulative prevalence of in-center hemodialysis is likely to compel hemodialysis patients to switch to home hemodialysis. The expansion of personalized users is anticipated to augment hemodialysis catheter sales.

Regional Analysis

The global chronic hemodialysis catheter market share is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

Asia pacific dominates the global market

Asia Pacific region is the highest contributor to the market and is expected to grow at a CAGR of 4.2% during the forecast period due to a rise in demand for hemodialysis catheter products, improved health awareness, advancements in healthcare infrastructure, a rise in the number of dialysis centers with advanced medical facilities, a surge in healthcare reforms, and an increase in the number of dialysis patients in emerging economies. Increased prevalence of chronic kidney disease and associated risk factors, such as diabetes, cardiovascular diseases, and hypertension, increased utilization of hemodialysis catheter products, and an increase in the number of patients receiving hemodialysis treatment is driving market growth in this region. In addition, the increased emphasis of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific nations in order to capitalize on high growth opportunities contributes to the expansion of the market. In addition, China is anticipated to grow at the highest CAGR during the forecast period, owing to the presence of the largest population, a significant surge in demand for advanced medical facilities, and an increase in R&D activities in the region's healthcare sector.

North America is expected to witness dynamic growth in the Chronic Hemodialysis Catheter market, with a CAGR of 3.7% during the forecast period. This is primarily attributable to technological advances in dialysis equipment and hemodialysis catheter, an increase in the prevalence of chronic kidney disease (CKD), and a rise in the number of dialysis patients. According to the Centers for Disease Control and Prevention, approximately 15% of U.S. adults had chronic kidney disease (CKD) in 2019. In addition, an increase in demand for hemodialysis catheter products, the presence of advanced healthcare facilities with trained medical professionals, and an increase in the number of research and development centers all contribute significantly to the expansion of the North American market. In addition, the market is propelled by a high incidence rate of chronic kidney disease, the presence of a large geriatric population, the ease of availability of hemodialysis catheter products, favorable reimbursement policies, and an increase in consumer awareness regarding their use.

Europe is expected to witness a significant CAGR of 2.3% in the chronic hemodialysis catheter market during the forecast period due to an increase in patient awareness of hemodialysis treatment, a large number of hospitals with trained medical personnel, an increase in the number of dialysis centers, and the presence of a large population of hemodialysis patients. The chronic hemodialysis catheter market in Germany, France, and the United Kingdom is expected to grow significantly due to the presence of a large number of key players and the presence of developed healthcare infrastructure with technologically advanced systems. The chronic hemodialysis catheter market in European countries is projected to grow at a steady rate during the forecast period, owing to a rise in demand for advanced hemodialysis catheter products and the strong presence of key players. Technological advancements in dialysis equipment & catheter technology, a lack of kidney donors for transplantation, and a high adoption rate of hemodialysis products also contribute positively to the market's growth in this region. In addition, the presence of developed infrastructure in the healthcare industry and the availability of trained professionals are major growth drivers for the Europe market.

The LAMEA region is expected to witness a moderate CAGR of 2.8% in the global chronic hemodialysis catheter market during the forecast period. LAMEA is an emerging market that is anticipated to provide lucrative growth opportunities for key players due to the rise in the target population, surge in demand for hemodialysis catheter products, and enhancement of healthcare infrastructure. In addition, the rise in the number of patients with end-stage renal disease (ESRD) in LAMEA drives the adoption of hemodialysis catheter products, thereby driving the market growth.

Segmental Analysis

The global chronic hemodialysis catheter market is segmented by type of tip, material, and end user. 

Based on the type of tip, the global market is bifurcated into step-tip, split-tip, and symmetric tip.

The step-tip segment is the highest contributor to the market and is expected to grow at a CAGR of 3.4% during the forecast period. Step-tip hemodialysis catheters are also referred to as staggered-tip catheters due to their staggered tip design. The outflow tip of these catheters extends a few centimeters past the inflow tip, preventing blood recirculation. Technological advancements in hemodialysis catheter products, the rise in prevalence of kidney diseases, the rise in demand for step-tip hemodialysis catheters, the surge in healthcare expenditure, the rise in public awareness towards hemodialysis treatment, and the rise in use of step-tip hemodialysis catheters in bloodstream infections among dialysis patients around the world are the key factors influencing the chronic hemodialysis catheter market growth of this segment.

The symmetric tip segment is expected to witness a higher CAGR of 4.5%. The symmetric-tip catheter has an optimized inner diameter and a Double D lumen symmetric design at its tip, without compromising the catheter's flexibility or strength. Due to its improved inner lumen design, the double D design is capable of sustaining high blood flow rates. Additionally, symmetric-tip catheters offer numerous advantages over other types of catheters, including low-access circulation and simple tip positioning. Increased utilization of symmetric hemodialysis catheters and rising preference for symmetric-tip catheters due to low access recirculation and ease of tip positioning are the primary growth drivers for this segment. In addition, symmetrical-tip catheters have a number of advantages over other catheter designs, including lower thrombosis rates, a lower dysfunction rate, increased catheter patency, and a decreased likelihood of re-intervention.

Based on material, the global market is bifurcated into silicone and polyurethane.

The polyurethane segment is the highest contributor to the market and is expected to grow at a CAGR of 3.7% during the forecast period. Polyurethane is composed of organic units connected by urethane (carbamate) bonds, and it is chemically inert once fully reacted. In addition, polyurethane has superior tensile strength and elongation, and polyurethane catheters can be extruded with thinner walls, resulting in a larger inner diameter for optimal blood flow. Catheters made from polyurethane offer advantages such as insertion simplicity, durability, and biocompatibility. The rise in adoption and demand for polyurethane hemodialysis catheters, unavailability of kidney donors for transplantation, and rise in the prevalence of end-stage renal disease (ESRD) are anticipated to drive the growth of the polyurethane hemodialysis catheter segment over the forecast period.

The silicone segment is expected to witness a higher CAGR of 3.37%. For the manufacture of hemodialysis catheters, medical-grade silicone is used. It has undergone biocompatibility testing and is suitable for a variety of medical applications, including cardiovascular, neurological, and others. Silicone offers several advantages, including softness, flexibility, and chemical resistance. In addition, silicone catheters do not cause any endothelial damage besides preventing venous perforations. Rise in the use of silicone hemodialysis catheters in both short-term and long-term vascular access for hemodialysis, a rise in cases of chronic kidney diseases, a rise in demand for silicone hemodialysis catheter products, and a rise in patient awareness regarding bloodstream infection (BSI) and hemodialysis treatment is anticipated to drive the growth of the silicone hemodialysis catheter segment during the forecast period.

Based on end-users, the global market is bifurcated into in-center dialysis and home dialysis.

The in-center dialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 3.5% during the forecast period. In-center dialysis is performed in hospitals, clinics, and independent dialysis centers. In-center hemodialysis can be performed with the assistance of a technician or a nurse in a dialysis center. Depending on the patient's response to treatment, in-center dialysis is typically administered three times per week for three to four hours per session. One of the benefits of in-center dialysis is that patients do not need medical training because the majority of tasks are performed by healthcare professionals, making it easier for patients to avoid making mistakes during treatment. Numerous governments and private organizations offer in-center dialysis programs and services to patients with ESRD and CKDs. Similarly, the majority of companies that develop hemodialysis products also operate dialysis centers in different regions.

The home dialysis segment is expected to witness a higher CAGR of 4.45%. Miniaturized dialysis equipment is typically used to perform home dialysis in the comfort of the patient's own home. Depending on the availability of patients, home dialysis can be performed frequently and for a longer period of time. So that dialysis can be performed safely, a trained family member must assist with the dialysis process. It is possible to perform hemodialysis and other dialysis procedures at home. Due to the similarity in clinical outcomes between in-center and home dialysis, many nations around the world encourage patients to choose home dialysis treatment. Additionally, countries with limited healthcare infrastructure can benefit from home dialysis.

Recent Developments

• April 2022, Medtronic and GE Healthcare partnered to meet the growing demand for outpatient care, focusing on care at Ambulatory Surgery Centers and Office Based Labs.
• July 2022, Nipro Medical Corporation invested EUR 13 million in Croatia for a new glass packaging plant for the pharmaceutical industry.